FIELD: medicine.
SUBSTANCE: invention relates to medications and deals with medicinal substance for inhibition of helicobacter-like erosion-ulcerous injuries of stomach mucosa, which contains as active component in efficient amount 9-(2-diethylaminoethyl)-2-phenyl-imidaso[1,2-a]benzimidasol dinitrate of formula I 
.
EFFECT: invention is aimed at extension of means for inhibition of helicobacter-like erosion-ulcerous injuries of stomach mucosa.
1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION HAVING ANTIULCER ACTIVITY, AND METHOD FOR PRODUCTION THEREOF | 2019 |
|
RU2736184C1 |
| ANTIULCER AGENT | 2022 |
|
RU2795979C1 |
| METHOD FOR PREVENTING EROSIVE AND ULCERATIVE LESIONS OF STOMACH AND DUODENUM DURING CHEMOTHERAPY | 2023 |
|
RU2806313C1 |
| METHOD FOR PREVENTING AND TREATING STRESS-INDUCED GASTRIC ULCER | 2013 |
|
RU2527683C1 |
| METHOD FOR PREVENTION OF GASTRIC MUCOSA ULCERATION | 2011 |
|
RU2481111C1 |
| EARLY DIAGNOSTIC TECHNIQUE FOR DUODENAL ULCER IN KHAKASS CAUCASIANS BY MOLECULAR GENETIC TESTING | 2013 |
|
RU2542459C1 |
| METHOD OF PREVENTING INJURY OF STOMACH MUCOSA CAUSED BY APPLICATION OF NON-STEROID ANTI-INFLAMMATORY MEDICATIONS | 2011 |
|
RU2455984C1 |
| METHOD FOR PREVENTING AND TREATING GASTRIC ULCER CAUSED BY ADMINISTRATION OF ETHANOL LIQUIDS | 2013 |
|
RU2527334C1 |
| METHOD FOR EVALUATING RISK OF DUODENAL ULCER IN KHAKASS BY GENETIC ANALYSIS | 2014 |
|
RU2563828C1 |
| METHOD FOR EARLY POSTOPERATIVE PREVENTION OF ACUTE GASTRODUODENAL ULCERS IN PATIENTS SUFFERING COLORECTAL CANCER | 2009 |
|
RU2403904C1 |
